Nasdaq bioc

SAN DIEGO, Sept. 4, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve patient outcomes, announces that, as a result of the Company's one-for-ten reverse stock split which will become effective at 5:00 p.m. Eastern Time on September 4, 2020, the Company's

Biocept (NASDAQ:BIOC) Earnings Information. Biocept last posted its quarterly earnings results on November 17th, 2020. The medical research company reported ($0.43) earnings per share for the quarter, topping analysts' consensus estimates of ($0.47) by $0.04. NASDAQ:BIOC Just look at this chart guys. Great ranging, beautiful breaks to the upside, followed by consolidation. These are the patterns we trade for. Wednesday will show us more of this picture, if it continues to look like these ranges we're in good shape. SAN DIEGO, Dec. 10, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, announces results from a prospective study showing Target Selector™ was highly accurate in monitoring HER2 alterations in patients with NasdaqCM:BIOC Income Statement, January 12th 2020 Does BIOC's size influence the expected beta? With a market capitalisation of US$13m, Biocept is a very small company by global standards.

Biocept, Inc. Common Stock (BIOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Top NASDAQ:BIOC Bull/Bear Pitches. The best Bull and Bear pitches based on recency and number of recommendations. 7 Sep 2020 Biocept Inc (NASDAQ:BIOC) announced that its common shares will begin trading on its new split-adjusted basis on the Nasdaq in New York at  Biocept Says Got Letter From Nasdaq Indicating Co Has Failed To Comply With Minimum Bid Price Requirement. Sept 27 (Reuters) - Biocept Inc 10% from $4.70 to $5.86. Nov. 14, 2020STOCK PRICE  Сравнить с индексом: NASDAQ Composite. Такая акция уже есть в сравнении . Выбрано максимально возможное количество акций для сравнения  Shareholder. Owner, in %. Freefloat, 99.98. Vanguard Group, Inc. (Subfiler), 4.83. Vanguard Total Stock Market Index Fund, 3.23. Vanguard Extended Market  US stock market today: stock quotes, stock screener, stock charts, insiders trading , market news, portfolio tracking, and cryptocurrencies.

If you're interested in Biocept, Inc. (NASDAQ:BIOC), then you might want to consider its beta (a measure of share

7‏‏/2‏‏/1442 بعد الهجرة 22‏‏/11‏‏/1441 بعد الهجرة 28‏‏/5‏‏/1441 بعد الهجرة 25‏‏/4‏‏/1442 بعد الهجرة TradingView UK. View live BIOCEPT INC chart to track its stock's price action. Find market predictions, BIOC financials and market news.

View Biocept, Inc. BIOC investment & stock information. Get the latest Biocept, Inc. BIOC detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Biocept, Inc. Common Stock (BIOC) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve Biocept, Inc. (NASDAQ:BIOC) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.43) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.04. The medical research company earned $6.59 million during the quarter, compared to analyst estimates of $1.20 million. Biocept, Inc. (NASDAQ:BIOC)’s share price rose 16.2% during mid-day trading on Tuesday . The company traded as high as $6.40 and last traded at $6.23. Approximately 2,143,389 shares traded hands during trading, an increase of 250% from the average daily volume of 612,817 shares. The stock had previously closed at $5.36. BIOC has been the […] 7‏‏/6‏‏/1442 بعد الهجرة قبل يوم

Jan 09, 2021 · Biocept, Inc. (NASDAQ:BIOC)’s traded shares stood at 466,195 during the last session, with the company’s beta value hitting 0.87. At the close of trading, the stock’s price was $5.15, to imply a decline of -0.19% or -$0.01 in intraday trading. The BIOC share’s 52-week high remains $13

Biocept, Inc. (NASDAQ:BIOC) posted its quarterly earnings results on Tuesday, November, 17th. The medical research company reported ($0.43) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.04. The medical research company earned $6.59 million during the quarter, compared to analyst estimates of $1.20 million. Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve

شاهد الرسوم البيانية لـ ‎biocept inc‎ لتتبع تحركات أسعارها. تعرّف على توقعات السوق، والأخبار ‎bioc‎ المالية ومستجداتها في الأسواق. Biocept Inc Share Price and News. Biocept, Inc. is a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically 20‏‏/11‏‏/1437 بعد الهجرة 25‏‏/4‏‏/1442 بعد الهجرة